venBio Partners’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.7M | Hold |
489,194
| – | – | 4.88% | 4 |
|
|
2025
Q4 | $18.3M | Hold |
489,194
| – | – | 8.46% | 3 |
|
|
2025
Q3 | $13.5M | Hold |
489,194
| – | – | 7.64% | 4 |
|
|
2025
Q2 | $15.5M | Hold |
489,194
| – | – | 13.47% | 2 |
|
|
2025
Q1 | $16.2M | Sell |
489,194
-50,000
| -9% | -$1.79M | 13.14% | 3 |
|
|
2024
Q4 | $18.6M | Sell |
539,194
-75,400
| -12% | -$2.59M | 10.87% | 3 |
|
|
2024
Q3 | $24.6M | Sell |
614,594
-420,802
| -41% | -$14.8M | 12.65% | 3 |
|
|
2024
Q2 | $31.2M | Hold |
1,035,396
| – | – | 13.49% | 4 |
|
|
2024
Q1 | $34.8M | Hold |
1,035,396
| – | – | 12.33% | 3 |
|
|
2023
Q4 | $33.4M | Hold |
1,035,396
| – | – | 5.01% | 4 |
|
|
2023
Q3 | $33.9M | Hold |
1,035,396
| – | – | 9.62% | 5 |
|
|
2023
Q2 | $36.4M | Hold |
1,035,396
| – | – | 13.19% | 4 |
|
|
2023
Q1 | $33.8M | Hold |
1,035,396
| – | – | 18.74% | 3 |
|
|
2022
Q4 | $57.1M | Sell |
1,035,396
-90,277
| -8% | -$4.96M | 17.69% | 3 |
|
|
2022
Q3 | $49.9M | Sell |
1,125,673
-323,047
| -22% | -$15.8M | 11.53% | 4 |
|
|
2022
Q2 | $70.7M | Sell |
1,448,720
-95,764
| -6% | -$4.31M | 20.12% | 2 |
|
|
2022
Q1 | $75.1M | Sell |
1,544,484
-1,195,927
| -44% | -$48.8M | 16.66% | 2 |
|
|
2021
Q4 | $117M | Sell |
2,740,411
-322,783
| -11% | -$12.9M | 21.05% | 2 |
|
|
2021
Q3 | $117M | Sell |
3,063,194
-441,430
| -13% | -$14.2M | 11.7% | 2 |
|
|
2021
Q2 | $98.9M | Hold |
3,504,624
| – | – | 11.68% | 2 |
|
|
2021
Q1 | $116M | Hold |
3,504,624
| – | – | 11% | 2 |
|
|
2020
Q4 | $127M | Hold |
3,504,624
| – | – | 11.18% | 2 |
|
|
2020
Q3 | $119M | Buy |
+3,504,624
| New | +$128M | 18.06% | 2 |
|
Other funds holding HRMY
VPM
VCM
AC